Pure Global AI
NCT06386614Recruiting

Effects of TDCS of the Frontal Lobe on Cognitive Function and BDNF in PSCI

The Second Hospital of Dalian Medical University
The Second Affiliated Hospital of Dalian Medical UniversityClinicalTrials.govother
Verified
Study focus
Disease/Condition
Stroke
Drug/Device/Intervention
Routine treatment
Study type
Interventional
Intervention type
other
Sponsor & location
Primary sponsor
The Second Affiliated Hospital of Dalian Medical University
Location
DaLian,Dalian, China
Timeline & enrollment
Phase
N/A
Start date
Jan 01, 2023
End date
Jun 01, 2024
Enrollment
40 participants
Primary outcome

BDNF

Summary

The purpose of the clinical trial is to find a treatment for stroke patients with cognitive
 impairment, and the main questions it aims to answer are:
 
 - [Search for effective treatments of cognitive impairment after stroke]
 
 - [explore the relationship between BDNF level and cognitive function] Participants will
 receive conventional treatment, tDCS treatment, .And then compare cognitive function and
 BDNF level

ICD-10 classifications
Stroke, not specified as haemorrhage or infarctionSequelae of stroke, not specified as haemorrhage or infarctionCerebral infarctionFamily history of strokeCerebral infarction, unspecified
Data source
Registry
ClinicalTrials.gov
Trial ID
NCT06386614
Type
Non-Device Trial
About this record

Access comprehensive clinical trial information for NCT06386614 through Pure Global AI's free database. This phase not specified trial is sponsored by The Second Affiliated Hospital of Dalian Medical University and is currently Recruiting. The study focuses on Stroke. Target enrollment is 40 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.